|Articles|March 1, 2017
- BioPharm International-03-01-2017
- Volume 30
- Issue 3
BioPharm International, March 2017 Issue (PDF)
Click the title above to open the BioPharm International March 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 9 years ago
Automating Bioprocessesalmost 9 years ago
Biosimilar Names Prove Difficult to Definealmost 9 years ago
Strategizing a Shortcut to Marketalmost 9 years ago
Covering Global Regulations in a Quality Systemalmost 9 years ago
Will Pharma Manufacturing Move Back to the US?almost 9 years ago
Serialization Hits the Home Stretchalmost 9 years ago
Harnessing Advances in Informatics to Ensure Data Integrityalmost 9 years ago
Being Thorough When Transferring TechnologyNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
2
Implementing Automation and Flexible Design for Allogeneic Manufacturing
3
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
4
Emerging siRNA Platform Offers New Metabolic Disorder Therapies
5
